View in EDS HTML Full Text PDF Full Text

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.

Saved in:
Bibliographic Details
Title: Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
Authors: Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Braun DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shukla SA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Pan W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gao X; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Hou Y; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Flaifel A; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Tang S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bosma-Moody A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Vokes N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nyman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Xie W; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Nassar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Abou Alaiwi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Flippot R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bouchard G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Steinharter JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ficial M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Sant'Angelo M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Dudani S; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Camp S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sticco-Ivins M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Hirsch L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wind-Rotolo M; Bristol-Myers Squibb, Princeton, NJ, USA., Ross-Macdonald P; Bristol-Myers Squibb, Princeton, NJ, USA., Sun M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee GM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chang SL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wei XX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Harshman LC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Genovese G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ellis L; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Atkins MB; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ho TH; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Linehan WM; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA., McDermott DF; Beth Israel Deaconess Medical Center, Boston, MA, USA., Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Viswanathan SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Toni_Choueiri@dfci.harvard.edu.
Source: Nature communications [Nat Commun] 2021 Feb 05; Vol. 12 (1), pp. 808. Date of Electronic Publication: 2021 Feb 05.
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33547292
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bakouny+Z%22">Bakouny Z</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Braun+DA%22">Braun DA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shukla+SA%22">Shukla SA</searchLink>; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pan+W%22">Pan W</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gao+X%22">Gao X</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hou+Y%22">Hou Y</searchLink>; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Flaifel+A%22">Flaifel A</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tang+S%22">Tang S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bosma-Moody+A%22">Bosma-Moody A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22He+MX%22">He MX</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Vokes+N%22">Vokes N</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nyman+J%22">Nyman J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Xie+W%22">Xie W</searchLink>; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nassar+AH%22">Nassar AH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Abou+Alaiwi+S%22">Abou Alaiwi S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Flippot+R%22">Flippot R</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bouchard+G%22">Bouchard G</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Steinharter+JA%22">Steinharter JA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nuzzo+PV%22">Nuzzo PV</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ficial+M%22">Ficial M</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sant'Angelo+M%22">Sant'Angelo M</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Forman+J%22">Forman J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Berchuck+JE%22">Berchuck JE</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dudani+S%22">Dudani S</searchLink>; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Bi+K%22">Bi K</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Park+J%22">Park J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Camp+S%22">Camp S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sticco-Ivins+M%22">Sticco-Ivins M</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hirsch+L%22">Hirsch L</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Baca+SC%22">Baca SC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wind-Rotolo+M%22">Wind-Rotolo M</searchLink>; Bristol-Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Ross-Macdonald+P%22">Ross-Macdonald P</searchLink>; Bristol-Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Sun+M%22">Sun M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+GM%22">Lee GM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chang+SL%22">Chang SL</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wei+XX%22">Wei XX</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22McGregor+BA%22">McGregor BA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Harshman+LC%22">Harshman LC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Genovese+G%22">Genovese G</searchLink>; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ellis+L%22">Ellis L</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pomerantz+M%22">Pomerantz M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hirsch+MS%22">Hirsch MS</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Freedman+ML%22">Freedman ML</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Atkins+MB%22">Atkins MB</searchLink>; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Wu+CJ%22">Wu CJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ho+TH%22">Ho TH</searchLink>; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Linehan+WM%22">Linehan WM</searchLink>; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22McDermott+DF%22">McDermott DF</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Heng+DYC%22">Heng DYC</searchLink>; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Viswanathan+SR%22">Viswanathan SR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Signoretti+S%22">Signoretti S</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Van+Allen+EM%22">Van Allen EM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Choueiri+TK%22">Choueiri TK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Toni_Choueiri@dfci.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 Feb 05; Vol. 12 (1), pp. 808. <i>Date of Electronic Publication: </i>2021 Feb 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33547292
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-021-21068-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 808
    Titles:
      – TitleFull: Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bakouny Z
      – PersonEntity:
          Name:
            NameFull: Braun DA
      – PersonEntity:
          Name:
            NameFull: Shukla SA
      – PersonEntity:
          Name:
            NameFull: Pan W
      – PersonEntity:
          Name:
            NameFull: Gao X
      – PersonEntity:
          Name:
            NameFull: Hou Y
      – PersonEntity:
          Name:
            NameFull: Flaifel A
      – PersonEntity:
          Name:
            NameFull: Tang S
      – PersonEntity:
          Name:
            NameFull: Bosma-Moody A
      – PersonEntity:
          Name:
            NameFull: He MX
      – PersonEntity:
          Name:
            NameFull: Vokes N
      – PersonEntity:
          Name:
            NameFull: Nyman J
      – PersonEntity:
          Name:
            NameFull: Xie W
      – PersonEntity:
          Name:
            NameFull: Nassar AH
      – PersonEntity:
          Name:
            NameFull: Abou Alaiwi S
      – PersonEntity:
          Name:
            NameFull: Flippot R
      – PersonEntity:
          Name:
            NameFull: Bouchard G
      – PersonEntity:
          Name:
            NameFull: Steinharter JA
      – PersonEntity:
          Name:
            NameFull: Nuzzo PV
      – PersonEntity:
          Name:
            NameFull: Ficial M
      – PersonEntity:
          Name:
            NameFull: Sant'Angelo M
      – PersonEntity:
          Name:
            NameFull: Forman J
      – PersonEntity:
          Name:
            NameFull: Berchuck JE
      – PersonEntity:
          Name:
            NameFull: Dudani S
      – PersonEntity:
          Name:
            NameFull: Bi K
      – PersonEntity:
          Name:
            NameFull: Park J
      – PersonEntity:
          Name:
            NameFull: Camp S
      – PersonEntity:
          Name:
            NameFull: Sticco-Ivins M
      – PersonEntity:
          Name:
            NameFull: Hirsch L
      – PersonEntity:
          Name:
            NameFull: Baca SC
      – PersonEntity:
          Name:
            NameFull: Wind-Rotolo M
      – PersonEntity:
          Name:
            NameFull: Ross-Macdonald P
      – PersonEntity:
          Name:
            NameFull: Sun M
      – PersonEntity:
          Name:
            NameFull: Lee GM
      – PersonEntity:
          Name:
            NameFull: Chang SL
      – PersonEntity:
          Name:
            NameFull: Wei XX
      – PersonEntity:
          Name:
            NameFull: McGregor BA
      – PersonEntity:
          Name:
            NameFull: Harshman LC
      – PersonEntity:
          Name:
            NameFull: Genovese G
      – PersonEntity:
          Name:
            NameFull: Ellis L
      – PersonEntity:
          Name:
            NameFull: Pomerantz M
      – PersonEntity:
          Name:
            NameFull: Hirsch MS
      – PersonEntity:
          Name:
            NameFull: Freedman ML
      – PersonEntity:
          Name:
            NameFull: Atkins MB
      – PersonEntity:
          Name:
            NameFull: Wu CJ
      – PersonEntity:
          Name:
            NameFull: Ho TH
      – PersonEntity:
          Name:
            NameFull: Linehan WM
      – PersonEntity:
          Name:
            NameFull: McDermott DF
      – PersonEntity:
          Name:
            NameFull: Heng DYC
      – PersonEntity:
          Name:
            NameFull: Viswanathan SR
      – PersonEntity:
          Name:
            NameFull: Signoretti S
      – PersonEntity:
          Name:
            NameFull: Van Allen EM
      – PersonEntity:
          Name:
            NameFull: Choueiri TK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 02
              Text: 2021 Feb 05
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1